Presentation:
Each modified release tablet contains Gliclazide BP 30 mg.
Indications:
Non insulin-dependent diabetes mellitus (type 2) in adults when dietary measures, physical exercise and weight loss alone are not sufficient to control blood glucose.
Commercial pack:
Each box contains 2 blister strips of 14 tablets.